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For several years I have used the intravenous route of inoculation to produce
rapidly fatal blastomycosis in mice for purposes of testing agents of possible
chemotherapeutic value for this disease. Although no substance thus far
studied has given evidence of promise in the treatment of this type of experi-
mental infection, the method is described because of the present—day interest in
the field of chemotherapy. For rapid screening of possible chemotherapeutic
agents experimental infections with a uniformly fatal outcome within a few days
are desirable. Such infections have the limitation that they are acute and do not
simulate the natural disease. They can, however, be used to detect the activity
of a therapeutic agent having a direct inhibitory effect on the infecting agent.
Infections in mice following the intraperitoneal inoculation of Blastomyces
dermatitidis have been described by several workers. In many cases a lethal
result was irregular and often occurred only after a considerable period (1, 2).
Spring (1) found the mouse to be the animal of choice but stated that death was
not to be expected. She also noted a difference in virulence for experimental
animals of different strains of the organism. Baker (3, 4) and Hitch (5) produced
uniformly fatal infections in mice by intraperitoneal inoculation of relatively
large doses of the organism. The time before death, however, was usually con-
siderably longer and more variable than was the case following intravenous in-
jection of certain of the doses used in the present study.
Hitch (5) inoculated several mice intravenously with Blastomyces derma-
titidis but abandoned the method because in his experience it always produced
immediate death. Such deaths following intravenous inoculation have not been
observed in my laboratory. Gilchrist and Stokes (6) produced pulmonary
blastomycosis in dogs by intravenous injection of material containing the organ-
ism. Following intravenous inoculation of large doses of the organism into
rabbits Gutierrez (7) found great numbers of miliary blastomycotic lesions in the
lungs.
Experiments were undertaken to determine the relationship of dosage to the
time of death following intravenous injection of the yeastlike and of the mycelial
phase of the organism. Two different strains of Blastomyces dermatitidis
were employed. Strain A had been isolated four years previously from the
meninges of a patient who had blastomycosis of the central nervous system and
strain B had been isolated three years previously from the skin of a patient
who had cutaneous blastomycosis. Both strains had been maintained in the
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yeastlike phase since isolation by weekly transfer on slants of dextrose agar
containing 10 per cent of horse serum and incubated at 37° C. The mice used
in this study were all young adults of the dilute brown strain (dba, subline
212) bred in the laboratory. In subsequent experiments, however, similar
results have been obtained with several other strains of mice.
Suspensions for inoculation were prepared in nutrient broth. The yeastlike
phase was obtained from heavily inoculated three day old cultures on dextrose-
serum-agar slants maintained at 37° C. The cells were dispersed by repeatedly
aspirating and ejecting the suspension through a Pasteur pipet drawn to a fine
point. The mycelial phase was obtained by scraping the mycelium from seven
to eight day cultures on dextrose-agar slants incubated at 30° C. Care was
taken to avoid the inclusion of agar in this material. A suspension of the
mycelium was prepared by gently grinding it in a mortar with a small amount
of broth and diluting to the desired density. The number of organisms in each
suspension was estimated by inoculating 1 ml. of each of a series of tenfold
dilutions into dextrose-agar pour plates, incubating these plates at 30° C.for
seven days and counting the colonies on plates containing from twenty to
200 colonies. The significance of the colony counts of the suspensions pre-
pared with the mycelial phase was subject to the limitation that the number of
separate viable elements determined by plating would vary with the degree of
fragmentation of mycelium resulting from grinding in the mortar.
Various dilutions of the primary suspensions in nutrient broth were prepared
for inoculation. Each dilution was injected intravenously into the tail veins
of several mice (usuaily four) in 0.1 ml. amounts, using a tuberculin syringe
and a 27 gauge needle. Since the organisms in the suspensions tended to settle
rapidly, the tube containing material for inoculation was shaken previous to
the inoculation of each mouse, the syringe immediately filled and the material
injected at once.
In each experiment a dose as large or twice as large as the largest dose given
intravenously was administered intraperitoneally to several mice to compare
the death time of two different routes of inoculation. Data on four experiments
are summarized in table 1. It is evident that the time of death following
intravenous inoculation was related to the dose. Even a small number of
organisms administered by this route caused death.
In experiments not listed in table 1 the intraperitoneal inoculation of small
doses of the two strains used in this study did not cause any symptoms in mice.
The intraperitoneal injection of relatively large doses of the organism, as shown
in table 1, usually gave a fatal result, but the interval between inoculation
and death was much longer and usually more variable than when a similar dose
was given intravenously. It is evident that both the mycelial and the yeast-
like form were virulent for mice.
After inoculation by either the intravenous or the intraperitoneal route there
were no immediate symptoms. In the ease of the intravenously inoculated
mice rapid and labored breathing was regularly observed from one to several
days before death.
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Necropsy was performed on every mouse. In mice dying within a short
period following intravenous injection of large doses of the organism the lungs
were found to be affected with a massive embolic pneumonia which had con-
verted them into a firm, gray, granulomatous mass. Their surfaces were
granular and there was a small amount of clear, sticky pleural exudate. Sections
of such lungs revealed numerous yeastlike forms of Blastomyces dermatiticlis.
Examination of the livers, kidneys and spleens of such mice rarely revealed
TABLE 1
Effect of size of dose on time of death following inoculation of Blastomyces
dermatitidis into mice
STRAIN IfiCE MICE DAY 01 AVERAGE01 PHASE OP PUNGUS ROUTE OP INOCULATION ORGM4ISMS INOCU- THAT DEATH DAY 01
UNGUS LATED DIED
A Yeastlike Intravenous 184,000 5 5 7—8 7
A Yeastlike Intravenous 92,000 4 4 7—12 9
A Yeastlike Intravenous 46,000 4 4 9—13 11
A Ycastlike Intravenous 9,200 4 4 11—15 13
A Yeastlike Intravenous 920 4 4 16—18 17
A Yeastlike Intravenous 92 4 4 23—32 26
A Yeastlike Intravenous 9 3 3 33—42 38
A Yeastlike Intraperitoneal 184,000 10 10 32—58 44
A Mycelial Intravenous 706,000 4 4 7—8 8
A Mycelial Intravenous 353,000 4 4 10—12 11
A Mycelial Intravenous 35,300 4 4 18—20 19
A Mycelial Intravenous 3,530 4 4 25—35 28
A Mycelial Intraperitoneal 706,000 4 4 27—33 30
B Yeastlike Intravenous 68,000 4 4 5—8 7
B Yeastlike Intravenous 6,800 4 4 11—13 12
B Yeastlike Intravenous 680 4 4 15—17 16
B Yeastlike Intravenous 68 4 4 23—28 25
B Yeastlike Intraperitoneal 136,000 4 4 17—25 21
B Mycelial Intravenous 14,000 4 4 10—17 13
B Mycelial Intravenous 1,400 4 4 19—20 20
B Mycelial Intravenous 140 4 4 24—32 28
B Mycelial Intravenous 14 4 1* 38 38
B Mycelial Intraperitoneal 28,000 4 2* 28—40 34
* Surviving animals killed on the fifty-third day after inoculation.
gross lesions but microscopic lesions were present fairly frequently. It was
evident that the mice died because of the extensive pneumonic involvement.
In mice dying at long intervals after the intravenous injection of small doses
of the organism discrete large tubercies were present in the lungs. With the
small doses few organisms were deposited in the lungs and death did not occur
until the infected foci had grown to a degree that caused death from respiratory
insufficiency. In such mice grossly visible tubercles of blastomycosis were
occasionally present in the liver, kidneys or spleen.
In mice dying following intraperitoneal inoculation there was usually exten-
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sive growth of blastomycotic tubercies on the peritoneal surfaces with frequent
involvement of the abdominal viscera and the lungs.
Since Spring (1) has noted differences in virulence of different strains of
Blastomyces dermatitidis for mice it is considered likely that not all strains of
the organism may kill mice with the regularity of the strains used in the present
study.
The process following intravenous injection of Blastomyces dermatitidis
into mice appears to be similar to that produced by the intravenous administra-
tion of Mycobacterium tuberculosis to this animal. The intravenous inocula-
tion into mice of large doses of virulent human strains of Mycobacterium tuber-
culosis results in fatal infections due to extensive involvement of the lungs (8).
Parsons (9) produced fatal infections in young mice by the intravenous
injection of very large doses of ilistoplasma capsulatum. In such infections
the disease process was generalized and an outstanding feature was striking
enlargement of the spleen, a condition not observed in experimental infections
with blastomycosis in mice.
SUMMARY
Uniform and rapidly fatal infections in mice have been produced by the
intravenous injection of the yeastlike and of the mycelial form of two different
strains of Blastomyces dermatitidis. The time of death was directly related
to the number of organisms administered. Death was due to embolic pneu-
monia.
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